FDA Clearance Tracker · P170032
Woven EndoBridge (WEB) Aneurysm Embolization System
Last checked: Nov 20, 2026Latest source record: Dec 31, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Dec 31, 2018
Approved
Time to decision
459 days
Received Sep 28, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170032
- Device name
- Woven EndoBridge (WEB) Aneurysm Embolization System
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Sep 28, 2017
- Decided
- Dec 31, 2018
- Decision
- Approved
- Supplements
- 21 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Intrasaccular Flow Disruption Device (OPR)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval for use in adults to embolize saccular intracranial wide neck bifurcation aneurysms located in the anterior (middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery (AComm) complex) and posterior (basilar apex) circulations, ranging in size from 3 mm to 10 mm in dome diameter, where the neck size is 4 mm or greater or the dome-to-neck ratio is greater than 1 and less than 2.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OPR (Intrasaccular Flow Disruption Device).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K261808 · Decided Jun 30, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261549 · Decided Jun 9, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.